Antiretroviral drugs and therapy (ART)

In 2001 the Thai Ministry of Public Health (MOPH) launched an antiretroviral therapy (ART) programme. A decentralized approach was adopted and treatment was initially provided to 1500 people living with HIV/AIDS (PLHA) in 112 government hospitals

The objective was to describe the causes of initial and overall AIDS-defining disease episodes among HIV patients in Singapore.

The report analyzes three alternative plans for using and financing antiretroviral therapy (ART) in India.

From 19 to 31 January 2004, a team of WHO experts visited Indonesia to assess the country's readiness for rapid scale-up of ART, to identify the technical support that will be needed, and to recommend urgent action towards achieving the time-bound target.

The primary objective of the antiretroviral therapy is to prolong the survival as well as improve the quality of life of the people living with HIV/AIDS. By bringing down the HIV viral load to sustained undetectable level, it is expected that ART will contribute also to HIV prevention.

This interim report on global efforts to increase access to ART focuses primarily on understanding the reasons for the successes and failures of scaling up HIV/AIDS interventions in different settings.

The main purpose of these guidelines is to assist health care providers in determining the optimal ART regimen for their HIV positive patients and to provide recommendations for standardized quality of care.

Standard operating procedures (SOPs) describe processes and provide instructions to maximize ART service delivery at health facilities in accordance with national guidelines.

This second report measures progress made by countries and describes how international partners are supporting their efforts. In addition, it summarizes how the building blocks of antiretroviral (ARV) therapy programmes are being put into place and how issues beyond treatment are being addressed.

This presentation summarizes the report which aims to study the baseline characteristics of enrolled patients in the first 3 1/2 months of SHC operation.